Citigroup Inc Novavax Inc Put Options Transaction History

Citigroup Inc

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	SELL	$10.71 - $17.11 $2.46 Million - $3.94 Million	-230,100 Reduced 24.71%	701,200 $8.86 Million
Q2 2024 Aug 12, 2024	BUY	$3.89 - $20.97 $3.62 Million - $19.5 Million	931,300 New	931,300 $11.8 Million
Q4 2023 Feb 09, 2024	SELL	$4.8 - $7.67 $4.05 Million - $6.47 Million	-843,600 Reduced 64.55%	463,200 $2.22 Million
Q3 2023 Nov 09, 2023	SELL	$6.81 - $9.74 $130,070 - $186,034	-19,100 Reduced 1.44%	1,306,800 $9.46 Million
Q2 2023 Aug 10, 2023	SELL	$6.67 - $9.52 $5.75 Million - $8.2 Million	-861,800 Reduced 39.39%	1,325,900 $9.85 Million
Q1 2023 May 11, 2023	BUY	$5.76 - $12.48 $5.93 Million - $12.9 Million	1,030,200 Added 89.0%	2,187,700 $15.2 Million
Q4 2022 Feb 09, 2023	BUY	$8.86 - $25.04 $1.75 Million - $4.94 Million	197,400 Added 20.56%	1,157,500 $11.9 Million
Q3 2022 Nov 10, 2022	BUY	$18.2 - $76.12 $10.7 Million - $44.9 Million	590,200 Added 159.56%	960,100 $17.5 Million
Q2 2022 Aug 10, 2022	SELL	$36.28 - $75.29 $43.6 Million - $90.4 Million	-1,201,200 Reduced 76.46%	369,900 $19 Million
Q1 2022 May 12, 2022	BUY	$69.73 - $142.9 $29.6 Million - $60.6 Million	424,000 Added 36.96%	1,571,100 $116 Million
Q4 2021 Feb 10, 2022	BUY	$134.56 - $217.97 $152 Million - $245 Million	1,126,300 Added 5414.9%	1,147,100 $164 Million
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $3.7 Million - $5.63 Million	20,800 New	20,800 $4.31 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.